| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L7 USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.08e-15 | 114 | 162 | 16 | GO:0004843 |
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L7 USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.24e-15 | 124 | 162 | 16 | GO:0101005 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L7 USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.11e-14 | 137 | 162 | 16 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L7 USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.18e-12 | 192 | 162 | 16 | GO:0008234 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L7 ERVK-6 USP17L21 TRABD2B USP17L23 USP17L12 NRDC USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 ERVK-7 USP17L19 CPM ACE USP17L18 USP17L17 ERVK-8 ERVK-18 USP17L6P KEL USP17L22 USP17L15 USP17L13 | 1.13e-10 | 654 | 162 | 25 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.32e-06 | 11 | 162 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.92e-06 | 14 | 162 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.34e-05 | 38 | 162 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.24e-05 | 21 | 162 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 3.28e-05 | 23 | 162 | 4 | GO:0030021 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.46e-05 | 46 | 162 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 4.25e-05 | 9 | 162 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.24e-04 | 37 | 162 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.24e-04 | 37 | 162 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.49e-04 | 38 | 162 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 2.97e-04 | 262 | 162 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | collagen binding | 5.15e-04 | 81 | 162 | 5 | GO:0005518 | |
| GeneOntologyMolecularFunction | structural constituent of tooth enamel | 9.60e-04 | 6 | 162 | 2 | GO:0030345 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 1.34e-03 | 59 | 162 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.52e-03 | 152 | 162 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | hydroxyapatite binding | 1.77e-03 | 8 | 162 | 2 | GO:0046848 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 5.43e-14 | 125 | 161 | 15 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 4.50e-13 | 144 | 161 | 15 | GO:0070646 |
| GeneOntologyBiologicalProcess | DNA integration | 2.42e-06 | 13 | 161 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.56e-05 | 48 | 161 | 5 | GO:0000731 | |
| GeneOntologyCellularComponent | basement membrane | 6.81e-06 | 122 | 169 | 8 | GO:0005604 | |
| Domain | HABP4_PAI-RBP1 | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 1.82e-22 | 16 | 160 | 12 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 1.82e-22 | 16 | 160 | 12 | IPR006861 |
| Domain | USP_CS | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 1.13e-14 | 66 | 160 | 13 | IPR018200 |
| Domain | USP_1 | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 2.54e-14 | 70 | 160 | 13 | PS00972 |
| Domain | UCH | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 3.09e-14 | 71 | 160 | 13 | PF00443 |
| Domain | USP_2 | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 3.09e-14 | 71 | 160 | 13 | PS00973 |
| Domain | USP_3 | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 3.75e-14 | 72 | 160 | 13 | PS50235 |
| Domain | USP_dom | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 3.75e-14 | 72 | 160 | 13 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L13 | 3.75e-14 | 72 | 160 | 13 | IPR001394 |
| Domain | LRRC37AB_C | 2.45e-06 | 4 | 160 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 2.45e-06 | 4 | 160 | 3 | PF14914 | |
| Domain | LRRC37_N | 2.45e-06 | 4 | 160 | 3 | IPR032754 | |
| Domain | LRRC37 | 2.45e-06 | 4 | 160 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 2.45e-06 | 4 | 160 | 3 | IPR015753 | |
| Domain | Amelogenin | 7.29e-05 | 2 | 160 | 2 | IPR004116 | |
| Domain | Amelogenin | 7.29e-05 | 2 | 160 | 2 | SM00818 | |
| Domain | Amelogenin | 7.29e-05 | 2 | 160 | 2 | PF02948 | |
| Domain | Envoplakin | 7.29e-05 | 2 | 160 | 2 | IPR030460 | |
| Domain | CTNNB1_binding | 4.33e-04 | 4 | 160 | 2 | PF08347 | |
| Domain | Cortactin-binding_p2_N | 4.33e-04 | 4 | 160 | 2 | IPR019131 | |
| Domain | TCF/LEF | 4.33e-04 | 4 | 160 | 2 | IPR024940 | |
| Domain | CTNNB1-bd_N | 4.33e-04 | 4 | 160 | 2 | IPR013558 | |
| Domain | CortBP2 | 4.33e-04 | 4 | 160 | 2 | PF09727 | |
| Domain | DUF4704 | 7.17e-04 | 5 | 160 | 2 | IPR031570 | |
| Domain | DUF4704 | 7.17e-04 | 5 | 160 | 2 | PF15787 | |
| Domain | BRK | 1.07e-03 | 6 | 160 | 2 | SM00592 | |
| Domain | PH_BEACH | 1.07e-03 | 6 | 160 | 2 | PF14844 | |
| Domain | BRK_domain | 1.07e-03 | 6 | 160 | 2 | IPR006576 | |
| Domain | BRK | 1.07e-03 | 6 | 160 | 2 | PF07533 | |
| Domain | HMG_box | 1.10e-03 | 53 | 160 | 4 | PF00505 | |
| Domain | HMG | 1.18e-03 | 54 | 160 | 4 | SM00398 | |
| Domain | - | 1.26e-03 | 55 | 160 | 4 | 1.10.30.10 | |
| Domain | - | 1.35e-03 | 95 | 160 | 5 | 2.60.120.200 | |
| Domain | Znf_U1 | 1.91e-03 | 29 | 160 | 3 | IPR003604 | |
| Domain | ZnF_U1 | 1.91e-03 | 29 | 160 | 3 | SM00451 | |
| Domain | Neurexophilin | 1.97e-03 | 8 | 160 | 2 | PF06312 | |
| Domain | PH-BEACH_dom | 1.97e-03 | 8 | 160 | 2 | IPR023362 | |
| Domain | Calx_beta | 1.97e-03 | 8 | 160 | 2 | SM00237 | |
| Domain | NXPH/NXPE | 1.97e-03 | 8 | 160 | 2 | IPR026845 | |
| Domain | - | 1.97e-03 | 8 | 160 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.97e-03 | 8 | 160 | 2 | PS51783 | |
| Domain | Ig_E-set | 2.02e-03 | 104 | 160 | 5 | IPR014756 | |
| Domain | EGF_LAM_2 | 2.11e-03 | 30 | 160 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 2.11e-03 | 30 | 160 | 3 | PS01248 | |
| Domain | HMG_box_dom | 2.34e-03 | 65 | 160 | 4 | IPR009071 | |
| Domain | Calx_beta | 2.52e-03 | 9 | 160 | 2 | IPR003644 | |
| Domain | BEACH | 2.52e-03 | 9 | 160 | 2 | PS50197 | |
| Domain | Beach | 2.52e-03 | 9 | 160 | 2 | PF02138 | |
| Domain | - | 2.52e-03 | 9 | 160 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.52e-03 | 9 | 160 | 2 | SM01026 | |
| Domain | BEACH_dom | 2.52e-03 | 9 | 160 | 2 | IPR000409 | |
| Domain | RFX_DNA_binding | 2.52e-03 | 9 | 160 | 2 | PF02257 | |
| Domain | DNA-bd_RFX | 2.52e-03 | 9 | 160 | 2 | IPR003150 | |
| Domain | Calx-beta | 2.52e-03 | 9 | 160 | 2 | PF03160 | |
| Domain | RFX_DBD | 2.52e-03 | 9 | 160 | 2 | PS51526 | |
| Domain | SNF2_N | 2.55e-03 | 32 | 160 | 3 | IPR000330 | |
| Domain | SNF2_N | 2.55e-03 | 32 | 160 | 3 | PF00176 | |
| Domain | SPEC | 2.55e-03 | 32 | 160 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.55e-03 | 32 | 160 | 3 | IPR018159 | |
| Domain | ConA-like_dom | 2.84e-03 | 219 | 160 | 7 | IPR013320 | |
| Domain | ZF_CCHC | 3.30e-03 | 35 | 160 | 3 | PS50158 | |
| Domain | EGF_Lam | 3.30e-03 | 35 | 160 | 3 | SM00180 | |
| Domain | Laminin_EGF | 3.30e-03 | 35 | 160 | 3 | PF00053 | |
| Domain | LRR_8 | 3.59e-03 | 171 | 160 | 6 | PF13855 | |
| Domain | Laminin_G_1 | 3.81e-03 | 11 | 160 | 2 | PF00054 | |
| Domain | LAM_G_DOMAIN | 4.18e-03 | 38 | 160 | 3 | PS50025 | |
| Domain | Laminin_EGF | 4.18e-03 | 38 | 160 | 3 | IPR002049 | |
| Domain | LRR_TYP | 4.24e-03 | 177 | 160 | 6 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 4.24e-03 | 177 | 160 | 6 | IPR003591 | |
| Domain | Znf_C2H2_matrin | 4.55e-03 | 12 | 160 | 2 | IPR000690 | |
| Domain | ZU5 | 4.55e-03 | 12 | 160 | 2 | PF00791 | |
| Domain | ZU5_dom | 4.55e-03 | 12 | 160 | 2 | IPR000906 | |
| Domain | Laminin_G_2 | 4.83e-03 | 40 | 160 | 3 | PF02210 | |
| Domain | CNH | 6.20e-03 | 14 | 160 | 2 | SM00036 | |
| Domain | LamG | 6.32e-03 | 44 | 160 | 3 | SM00282 | |
| Domain | CNH | 7.12e-03 | 15 | 160 | 2 | PF00780 | |
| Domain | CNH | 7.12e-03 | 15 | 160 | 2 | PS50219 | |
| Domain | CNH_dom | 7.12e-03 | 15 | 160 | 2 | IPR001180 | |
| Domain | LRR | 7.78e-03 | 201 | 160 | 6 | PS51450 | |
| Domain | Laminin_N | 8.09e-03 | 16 | 160 | 2 | IPR008211 | |
| Domain | LamNT | 8.09e-03 | 16 | 160 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 8.09e-03 | 16 | 160 | 2 | PS51117 | |
| Domain | Laminin_N | 8.09e-03 | 16 | 160 | 2 | PF00055 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 6.44e-19 | 45 | 120 | 14 | MM15671 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 8.31e-10 | 191 | 120 | 14 | MM15289 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 TNIP2 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 6.06e-09 | 262 | 120 | 15 | MM15286 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 4.85e-08 | 221 | 120 | 13 | M27578 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P IRS2 USP17L22 USP17L15 USP17L13 | 8.01e-08 | 318 | 120 | 15 | MM15278 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L12 USP17L20 USP17L11 TNIP2 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L22 USP17L15 USP17L13 | 2.45e-07 | 299 | 120 | 14 | M27574 |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | USP17L7 AMELX AMELY USP17L21 MGAT4B SATB2 CCDC22 ARSJ USP17L12 USP17L20 USP17L11 TNIP2 USP17L5 USP17L10 USP17L19 CPM USP17L18 MAN1A2 USP17L17 NFKB2 SHPRH USP17L6P GALNT5 USP17L22 NUP160 USP17L15 AMTN USP17L13 | 1.14e-05 | 1389 | 120 | 28 | MM15307 |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.72e-05 | 42 | 120 | 5 | M27272 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 6.91e-05 | 10 | 120 | 3 | MM15156 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.49e-04 | 32 | 120 | 4 | MM14975 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 2.04e-04 | 14 | 120 | 3 | M27402 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | AMELX USP17L21 MGAT4B SATB2 CCDC22 ARSJ USP17L12 USP17L20 USP17L11 TNIP2 USP17L24 USP17L5 USP17L10 USP17L19 CPM USP17L18 MAN1A2 USP17L17 NFKB2 SHPRH GALNT5 USP17L22 NUP160 USP17L15 AMTN USP17L13 | 2.36e-04 | 1475 | 120 | 26 | M19806 |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.16e-28 | 21 | 171 | 14 | 8622927 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.16e-28 | 21 | 171 | 14 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.16e-28 | 21 | 171 | 14 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.16e-28 | 21 | 171 | 14 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.16e-28 | 21 | 171 | 14 | 12447969 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.16e-28 | 21 | 171 | 14 | 18980247 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 8.66e-28 | 22 | 171 | 14 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 5.26e-27 | 24 | 171 | 14 | 8995226 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.19e-26 | 25 | 171 | 14 | 21115691 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.22e-26 | 33 | 171 | 15 | 20228807 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 20403174 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 15780755 |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 19188362 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 11941478 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 17109758 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 20388806 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 9806828 |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 20368735 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 10936051 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.17e-26 | 34 | 171 | 15 | 21448158 | |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.57e-26 | 26 | 171 | 14 | 35816173 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.78e-26 | 35 | 171 | 15 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 3.78e-26 | 35 | 171 | 15 | 21239494 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 6.44e-26 | 36 | 171 | 15 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.08e-25 | 37 | 171 | 15 | 20228808 |
| Pubmed | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.04e-25 | 29 | 171 | 14 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 2.26e-21 | 50 | 171 | 14 | 31806660 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | LRRC8E HSPG2 FRAS1 MGAT4B ARSJ ZNF628 TRIO PHF12 AOC2 PER1 CHD8 MIB2 ITGB4 SH3BP4 HIVEP3 DACT1 TNRC18 KMT2D PNPLA6 EIF4ENIF1 NBEAL2 NEK8 SBF2 NFKB2 CSPG4 STRN4 IRS2 HTT | 1.12e-12 | 1105 | 171 | 28 | 35748872 |
| Pubmed | USP17L7 HAUS7 USP17L21 USP17L12 USP17L20 NXPE4 USP17L11 USP17L5 USP17L10 USP17L19 TLX2 USP17L18 KMT2D USP17L17 USP17L6P KLHL33 USP17L22 USP17L15 USP17L13 | 1.12e-09 | 674 | 171 | 19 | 37196079 | |
| Pubmed | SOX6 SATB2 ETV6 LASP1 RFX3 PKHD1L1 LENG9 HIVEP3 MTF1 ARID2 NFKB2 SCAPER CIZ1 ZNF638 ZNF598 LEF1 POU2F3 TCF7L1 MNT | 2.09e-08 | 808 | 171 | 19 | 20412781 | |
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 6.97e-08 | 9 | 171 | 4 | 17335794 | |
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 22419166 | ||
| Pubmed | CAD CCDC22 HAUS5 BAG3 MPDZ CHD8 GTF3C4 KMT2D ARID2 STRN4 CIZ1 ZNF598 SAP130 HTT | 6.39e-07 | 549 | 171 | 14 | 38280479 | |
| Pubmed | CDC42BPG FRAS1 MGAT4B NRDC RPS6KA1 PKP4 PEX1 MPDZ CHD8 MIB2 SIK3 SH3BP4 TMEM177 TONSL ZNF638 | 8.76e-07 | 650 | 171 | 15 | 38777146 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.16e-06 | 5 | 171 | 3 | 12629516 | |
| Pubmed | Notch Signaling Pathway in Tooth Shape Variations throughout Evolution. | 1.64e-06 | 18 | 171 | 4 | 36899896 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17 | 2.17e-06 | 119 | 171 | 7 | 28625976 |
| Pubmed | SOX6 HSPG2 ARHGAP32 SATB2 CAD PHF12 PEG10 TNIP2 TLX3 ETV6 CHD8 LASP1 TLX2 KMT2D EIF4ENIF1 ARID2 NFKB2 ZNF638 CTBP2 SAP130 MNT FILIP1L | 2.25e-06 | 1429 | 171 | 22 | 35140242 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 7.36e-06 | 94 | 171 | 6 | 21542922 | |
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 9.06e-06 | 27 | 171 | 4 | 31541017 | |
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 29684584 | ||
| Pubmed | Sox21 Regulates Anapc10 Expression and Determines the Fate of Ectodermal Organ. | 1.05e-05 | 28 | 171 | 4 | 32674056 | |
| Pubmed | PHF12 PKP4 HAUS5 PER1 PEX1 RNF213 CHD9 CHD8 SIK3 PNPLA6 EIF4ENIF1 ARID2 SCAPER CIZ1 IRS2 DDX41 SAP130 TCF7L1 | 1.08e-05 | 1116 | 171 | 18 | 31753913 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 1.10e-05 | 212 | 171 | 8 | 33853758 | |
| Pubmed | 1.11e-05 | 101 | 171 | 6 | 10997877 | ||
| Pubmed | Sox2 and Lef-1 interact with Pitx2 to regulate incisor development and stem cell renewal. | 1.37e-05 | 10 | 171 | 3 | 27660324 | |
| Pubmed | 1.37e-05 | 10 | 171 | 3 | 23064749 | ||
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 1.37e-05 | 10 | 171 | 3 | 24207026 | |
| Pubmed | Ectodermal Organ Development Is Regulated by a microRNA-26b-Lef-1-Wnt Signaling Axis. | 1.87e-05 | 11 | 171 | 3 | 32760291 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18346915 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8297387 | ||
| Pubmed | Human and mouse amelogenin gene loci are on the sex chromosomes. | 2.40e-05 | 2 | 171 | 2 | 2737677 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 19086270 | ||
| Pubmed | Hierarchical self-assembly of amelogenin and the regulation of biomineralization at the nanoscale. | 2.40e-05 | 2 | 171 | 2 | 21825148 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23883486 | ||
| Pubmed | Amelogenin: a potential regulator of cementum-associated genes. | 2.40e-05 | 2 | 171 | 2 | 14653387 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 7489712 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 26709694 | ||
| Pubmed | Comparison of body weight and gene expression in amelogenin null and wild-type mice. | 2.40e-05 | 2 | 171 | 2 | 16674684 | |
| Pubmed | Amelogenin-collagen interactions regulate calcium phosphate mineralization in vitro. | 2.40e-05 | 2 | 171 | 2 | 20404336 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18394981 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 23896516 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 34281250 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1427830 | ||
| Pubmed | Transgene animal model for protein expression and accumulation into forming enamel. | 2.40e-05 | 2 | 171 | 2 | 11063035 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 10200911 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 2004775 | ||
| Pubmed | Loss of biological control of enamel mineralization in amelogenin-phosphorylation-deficient mice. | 2.40e-05 | 2 | 171 | 2 | 35219810 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 2689082 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 16707492 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21984897 | ||
| Pubmed | Cryogenic transmission electron microscopy study of amelogenin self-assembly at different pH. | 2.40e-05 | 2 | 171 | 2 | 21597263 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8392462 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20923441 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17189292 | ||
| Pubmed | Protein interactions during assembly of the enamel organic extracellular matrix. | 2.40e-05 | 2 | 171 | 2 | 9041053 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 12667550 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 3253061 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 29462330 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8618899 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 31621902 | ||
| Pubmed | Leucine rich amelogenin peptide alters ameloblast differentiation in vivo. | 2.40e-05 | 2 | 171 | 2 | 23747796 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1445358 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 21540557 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 19097165 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 24362885 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 15647828 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 4015654 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 10498690 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 27246400 | ||
| Pubmed | Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice. | 2.40e-05 | 2 | 171 | 2 | 34780561 | |
| Pubmed | Comparison of upstream regions of X- and Y-chromosomal amelogenin genes. | 2.40e-05 | 2 | 171 | 2 | 9714776 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 34331233 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 31919099 | ||
| Pubmed | The small bovine amelogenin LRAP fails to rescue the amelogenin null phenotype. | 2.40e-05 | 2 | 171 | 2 | 12958690 | |
| Pubmed | [Types and frequencies of variants in Amelogenin gene in Chinese population]. | 2.40e-05 | 2 | 171 | 2 | 18067069 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 22653892 | ||
| Pubmed | Mouse amelogenin exons 8 and 9: sequence analysis and protein distribution. | 2.40e-05 | 2 | 171 | 2 | 15972588 | |
| Interaction | TOP3B interactions | LRRC8E HSPG2 FRAS1 MGAT4B CAD ARSJ ZNF628 TRIO PHF12 AOC2 PER1 CHD8 MIB2 ITGB4 SH3BP4 HIVEP3 DACT1 TNRC18 KMT2D PNPLA6 EIF4ENIF1 NBEAL2 NEK8 SBF2 NFKB2 CSPG4 STRN4 IRS2 ZNF598 HTT | 9.77e-07 | 1470 | 157 | 30 | int:TOP3B |
| Cytoband | 4p16.1 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 7.88e-22 | 79 | 170 | 15 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L23 USP17L12 USP17L20 USP17L11 TNIP2 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P POLN USP17L22 USP17L15 HTT USP17L13 | 4.70e-19 | 222 | 170 | 18 | chr4p16 |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 5.06e-04 | 7 | 90 | 2 | 570 | |
| GeneFamily | EF-hand domain containing|Plakins | 6.73e-04 | 8 | 90 | 2 | 939 | |
| GeneFamily | HAUS augmin like complex | 6.73e-04 | 8 | 90 | 2 | 581 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 8.62e-04 | 9 | 90 | 2 | 1230 | |
| GeneFamily | Non-clustered protocadherins | 1.57e-03 | 12 | 90 | 2 | 21 | |
| GeneFamily | AAA ATPases|Peroxins | 2.81e-03 | 16 | 90 | 2 | 957 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.56e-03 | 18 | 90 | 2 | 1160 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.90e-16 | 86 | 161 | 14 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 8.76e-15 | 112 | 161 | 14 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 BAG3 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 7.17e-14 | 160 | 161 | 15 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 APOBEC1 USP17L19 LASP1 ITGB4 USP17L18 USP17L17 NBEAL2 USP17L6P SERINC3 USP17L22 USP17L15 USP17L13 | 1.95e-08 | 647 | 161 | 19 | MM981 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L7 USP17L21 CAD USP17L12 NRDC USP17L20 USP17L11 PER1 USP17L5 USP17L10 USP17L19 ITGAL TLCD2 USP17L18 EIF4ENIF1 USP17L17 USP17L6P USP17L22 POU2F3 USP17L15 USP17L13 | 2.77e-06 | 1072 | 161 | 21 | MM1031 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 1.38e-05 | 176 | 161 | 8 | M39223 | |
| Coexpression | GAL_LEUKEMIC_STEM_CELL_UP | 1.62e-05 | 130 | 161 | 7 | M17428 | |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP | 3.34e-05 | 199 | 161 | 8 | M5233 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 6.51e-05 | 111 | 161 | 6 | M45685 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L5 USP17L10 APOBEC1 USP17L19 LASP1 ITGB4 USP17L18 FICD USP17L17 NBEAL2 USP17L6P SERINC3 USP17L22 USP17L15 USP17L13 | 6.66e-05 | 1226 | 161 | 20 | MM979 |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-07 | 175 | 157 | 8 | a3f8c54c77bce9b035a4835945ab341909be4946 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.53e-07 | 199 | 157 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-06 | 172 | 157 | 7 | f814b6134ad608015765399d54cc1e5e1873ed34 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-06 | 186 | 157 | 7 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 188 | 157 | 7 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 188 | 157 | 7 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 188 | 157 | 7 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 188 | 157 | 7 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-06 | 188 | 157 | 7 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.95e-06 | 189 | 157 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.30e-06 | 191 | 157 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.49e-06 | 192 | 157 | 7 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-06 | 192 | 157 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 5.68e-06 | 193 | 157 | 7 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 157 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 194 | 157 | 7 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-05 | 161 | 157 | 6 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-05 | 167 | 157 | 6 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-05 | 167 | 157 | 6 | 8fede587572d465cb63f7828141a574185bbb819 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 172 | 157 | 6 | 1f335ccb92b22d0412954e8fc3af212f96410b67 | |
| ToppCell | droplet-Liver-nan-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-05 | 172 | 157 | 6 | bb96c896d125e10b71e94e2bdad243899045af5c | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-05 | 172 | 157 | 6 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 173 | 157 | 6 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 173 | 157 | 6 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.58e-05 | 174 | 157 | 6 | 9e5fae9ecc7c0111fc8a252e72b89dc89c0d3a7c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Gad2-Inhibitory_Neuron.Gad1Gad2.Gad2-Kcnc3_(GABAergic,_K/Na_Channel_State)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 53 | 157 | 4 | a58b0b1c9991cfebf20e206a129b79f494785138 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Gad2-Inhibitory_Neuron.Gad1Gad2.Gad2-Kcnc3_(GABAergic,_K/Na_Channel_State)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 53 | 157 | 4 | e90685a7c6ef223783b1c1a6b1896fd566449422 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Gad2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.66e-05 | 53 | 157 | 4 | 5ad1a5c5c9a1dc66dd7e6de6edbee0176678966c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.93e-05 | 177 | 157 | 6 | f28243b51be104cb3adcde63f03fc2206ed3121e | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 177 | 157 | 6 | 65709bd546cb1ec6aa2ddd8b2adb46e174eb9a9a | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 177 | 157 | 6 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.93e-05 | 177 | 157 | 6 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 177 | 157 | 6 | 8684d47a547e2a06496f15e8da0200ecddc431e0 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.06e-05 | 178 | 157 | 6 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-05 | 182 | 157 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.60e-05 | 182 | 157 | 6 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.74e-05 | 183 | 157 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.88e-05 | 184 | 157 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.03e-05 | 185 | 157 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-05 | 186 | 157 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-05 | 186 | 157 | 6 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.34e-05 | 187 | 157 | 6 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.34e-05 | 187 | 157 | 6 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-05 | 188 | 157 | 6 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 190 | 157 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 191 | 157 | 6 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.01e-05 | 191 | 157 | 6 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | control-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.01e-05 | 191 | 157 | 6 | afebdc59a1f884ce3f2f5fe040e16b0e95e4e7c5 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 192 | 157 | 6 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.18e-05 | 192 | 157 | 6 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 6.18e-05 | 192 | 157 | 6 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.36e-05 | 193 | 157 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.36e-05 | 193 | 157 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-05 | 194 | 157 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 6.55e-05 | 194 | 157 | 6 | b46c54802b8d1e0a0a17f9ed8e82eaf5e7f4849d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.74e-05 | 195 | 157 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.93e-05 | 196 | 157 | 6 | 7acd782a587b7d331517f60daa8b5c2177bedfc7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 196 | 157 | 6 | 184104cbea0461dd2757668ab9755948ac7b585a | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 196 | 157 | 6 | bebb20dc210576101c317011e3afb59798f5d255 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.93e-05 | 196 | 157 | 6 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.93e-05 | 196 | 157 | 6 | 8114e98923096c54b6834f21550c3061bab6773d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.13e-05 | 197 | 157 | 6 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 7.13e-05 | 197 | 157 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.13e-05 | 197 | 157 | 6 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-05 | 197 | 157 | 6 | 77fe092aae8f05fe137680506892d2f61071d6ea | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.13e-05 | 197 | 157 | 6 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.24e-05 | 122 | 157 | 5 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.33e-05 | 198 | 157 | 6 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.33e-05 | 198 | 157 | 6 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 198 | 157 | 6 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.53e-05 | 199 | 157 | 6 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.75e-05 | 200 | 157 | 6 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 7.75e-05 | 200 | 157 | 6 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | LPS_only-Mesenchymal_myocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 7.75e-05 | 200 | 157 | 6 | 8bc9923f82bfb836e2f524204c92050edeae8ca5 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.21e-04 | 136 | 157 | 5 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.43e-04 | 141 | 157 | 5 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Lung / Manually curated celltypes from each tissue | 1.48e-04 | 142 | 157 | 5 | c3db15bcb305ebdf5c9ca0b5c8ce63fab978590b | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 143 | 157 | 5 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.58e-04 | 77 | 157 | 4 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Calb2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.75e-04 | 79 | 157 | 4 | 03c5af851b53800eced1c74e9da374c71092bcd4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.03e-04 | 152 | 157 | 5 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-04 | 153 | 157 | 5 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.10e-04 | 153 | 157 | 5 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.10e-04 | 153 | 157 | 5 | 92a5307b8e4dcf9ee42134b4c0645f9d488df61a | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-04 | 157 | 157 | 5 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.43e-04 | 158 | 157 | 5 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.50e-04 | 159 | 157 | 5 | ba82d1f55dd77c4b2183981b76cab1480fba75ad | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 160 | 157 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.58e-04 | 160 | 157 | 5 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 160 | 157 | 5 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 160 | 157 | 5 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 160 | 157 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | severe_influenza-CD8+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 2.65e-04 | 161 | 157 | 5 | 82196139cdbbd70a36957a87bc9ac6d02575da3f | |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 CHD9 CHD8 USP17L10 USP17L19 USP17L18 KMT2D USP17L17 USP17L6P USP17L22 SAP130 USP17L15 USP17L13 | 7.44e-28 | 69 | 157 | 19 | DOID:1682 (implicated_via_orthology) |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L7 USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13 | 1.74e-23 | 46 | 157 | 15 | DOID:5426 (implicated_via_orthology) |
| Disease | amelogenesis imperfecta type 1E (implicated_via_orthology) | 2.81e-05 | 2 | 157 | 2 | DOID:0110058 (implicated_via_orthology) | |
| Disease | Amelogenesis Imperfecta | 3.14e-05 | 12 | 157 | 3 | C0002452 | |
| Disease | Osteoarthritis of hip | 1.58e-04 | 20 | 157 | 3 | C0029410 | |
| Disease | autosomal dominant hypocalcemia (biomarker_via_orthology) | 1.68e-04 | 4 | 157 | 2 | DOID:0090109 (biomarker_via_orthology) | |
| Disease | myeloproliferative neoplasm (is_implicated_in) | 1.68e-04 | 4 | 157 | 2 | DOID:2226 (is_implicated_in) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.69e-04 | 152 | 157 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | ficolin-2 measurement | 2.78e-04 | 5 | 157 | 2 | EFO_0008135 | |
| Disease | SUN domain-containing protein 3 measurement | 2.78e-04 | 5 | 157 | 2 | EFO_0802102 | |
| Disease | response to silica exposure, pneumoconiosis | 2.78e-04 | 5 | 157 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | Zellweger syndrome (implicated_via_orthology) | 4.16e-04 | 6 | 157 | 2 | DOID:905 (implicated_via_orthology) | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 5.80e-04 | 7 | 157 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Amelogenesis Imperfecta hypomaturation type | 7.71e-04 | 8 | 157 | 2 | C0399372 | |
| Disease | reaction time measurement | SOX6 TNIK SATB2 TRABD2B LRRC37A2 CCDC92 HNF4G KMT2D ZNF638 PACRG RPS6KL1 | 8.29e-04 | 658 | 157 | 11 | EFO_0008393 |
| Disease | Calcium channel blocker use measurement | 1.01e-03 | 213 | 157 | 6 | EFO_0009930 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 1.50e-03 | 11 | 157 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER) | 1.50e-03 | 11 | 157 | 2 | C4721541 | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.50e-03 | 11 | 157 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Zellweger Spectrum | 2.11e-03 | 13 | 157 | 2 | C3658299 | |
| Disease | Zellweger-Like Syndrome | 2.11e-03 | 13 | 157 | 2 | C0751594 | |
| Disease | Infantile Refsum Disease (disorder) | 2.11e-03 | 13 | 157 | 2 | C0282527 | |
| Disease | leukemia (is_implicated_in) | 2.11e-03 | 13 | 157 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | blood phosphate measurement | 2.44e-03 | 174 | 157 | 5 | EFO_0010972 | |
| Disease | atrial fibrillation (is_implicated_in) | 2.45e-03 | 14 | 157 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | Autistic Disorder | 2.81e-03 | 261 | 157 | 6 | C0004352 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 2.82e-03 | 15 | 157 | 2 | EFO_0008223 | |
| Disease | Peroxisome biogenesis disorders | 2.82e-03 | 15 | 157 | 2 | C1832200 | |
| Disease | Adrenoleukodystrophy, Neonatal | 2.82e-03 | 15 | 157 | 2 | C0282525 | |
| Disease | Antihypertensive use measurement | 3.03e-03 | 265 | 157 | 6 | EFO_0009927 | |
| Disease | Zellweger Syndrome | 3.21e-03 | 16 | 157 | 2 | C0043459 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 3.21e-03 | 16 | 157 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.50e-03 | 57 | 157 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Amelogenesis imperfecta | 3.63e-03 | 17 | 157 | 2 | cv:C0002452 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VPQHLGPSLQRTVHD | 346 | Q99569 | |
| LHHQIIPVLSQQHPP | 61 | Q99217 | |
| HGQIHQPLPHSAQLI | 271 | Q14032 | |
| HHTETVFNRVLPGPI | 2396 | Q9HCK8 | |
| LHHQIIPVVSQQHPL | 76 | Q99218 | |
| IPVVSQQHPLTHTLQ | 81 | Q99218 | |
| IPVTHNLPTVAHPSQ | 411 | P56545 | |
| VLLHNSVPVADGQPH | 271 | Q6UVK1 | |
| LVSEEPLHAGQPHFL | 1761 | Q6UVK1 | |
| HLPLLNQLPSGHSKV | 1331 | Q96M83 | |
| QTIPPHILLATGLIH | 216 | P41238 | |
| AQHINLEGPIPAHLL | 866 | P12821 | |
| RILEVTDQPHNLTPH | 141 | Q8IZF6 | |
| PQPVTVVNSQTLLHH | 751 | Q68CP9 | |
| ESVELVLPPHANHQG | 221 | Q8WXI4 | |
| HPHVLPIFVTQLGAQ | 96 | Q6UX39 | |
| HLQLVGTVHASVPEP | 441 | O43246 | |
| VPQPVGRVASLLEHH | 196 | O60826 | |
| TANQAQVVPGLVHHP | 46 | Q96MC9 | |
| QPAVSSPHHIIPQKQ | 266 | Q8N7E2 | |
| QHVPGTQPHLDQSIV | 261 | Q5RIA9 | |
| EQQPHHLATAVPLTP | 121 | Q7L9B9 | |
| HPNIQGISKHPIQIT | 576 | Q7Z5Q5 | |
| QQPLPVHQPHSLVSE | 26 | Q96M98 | |
| NIILEHHVAQEPSPG | 1036 | P98160 | |
| HQVHGPLLRLNQVSP | 2871 | P98160 | |
| LISPPTNFNHLVHVG | 1436 | Q6DT37 | |
| LVPTINGTLPIRSHH | 761 | Q9HCL0 | |
| PAIVTPQVKQEHPHT | 261 | Q9UJU2 | |
| IQIHSPLGIHIPLES | 601 | O75106 | |
| PHPNIEQTIHQVSLD | 706 | Q8TDY2 | |
| PGNSIHTQPEVILHQ | 136 | P41212 | |
| LLSILDVITGHQHPQ | 266 | Q8IY17 | |
| AVQHIALVPTPHQTK | 516 | A6NCF5 | |
| PNVVVAQPPEHSHLT | 526 | O60309 | |
| PEVTLPHPDQVQTQH | 641 | O60309 | |
| HTPSLHVNGSLILPI | 1101 | Q86XX4 | |
| TLPLHPNQGIIEHRD | 1506 | Q86XX4 | |
| HISVQIPHQDGMLPL | 3336 | Q86XX4 | |
| PLRSHLEPTNHAVIQ | 436 | P43026 | |
| PPANHTPCVVQVHTL | 101 | P78508 | |
| VLHTNLNVQSTHPPL | 16 | Q6NUN7 | |
| PNVVVAQPPEHSHLT | 526 | A6NM11 | |
| PEVTLPHPDQVQTQH | 641 | A6NM11 | |
| PNVVVAQPPEHSHLT | 526 | A6NMS7 | |
| PEVTLPHPDQVQTQH | 641 | A6NMS7 | |
| EIHSGLLEVISPSPH | 206 | Q9UQ53 | |
| PARTHEEQHNLPVIG | 81 | P61550 | |
| IHLSSLPEPLLHQTQ | 306 | Q86WG5 | |
| EPGEVQPQTLQHHII | 456 | A6NM62 | |
| IHTGLQHSIIRPTQP | 136 | Q5FYB0 | |
| AISINIPQHPATLHS | 2896 | Q2LD37 | |
| TTQVLVGHHIPPHPQ | 311 | Q9BVA6 | |
| LEQQQPHHIPTSAPV | 156 | Q14847 | |
| QHVPGTQPHLDQSIV | 261 | Q8IUF1 | |
| QHVPGTQPHLDQSIV | 261 | Q9BRT8 | |
| EQIHRLLLQPVHSPS | 491 | O15534 | |
| STLQSPGQLHPHLTV | 436 | Q96B70 | |
| LRHPAVGPIQAHQEA | 251 | A8MZ36 | |
| LRHPAVGPIQAHQEA | 296 | Q92817 | |
| VLPHLQVQHLTGGLI | 1931 | Q92817 | |
| PIASGPVVHETHDLI | 406 | Q86TG7 | |
| HLSLGEEPVPHQQVE | 531 | Q86SG6 | |
| ITHIRAHTNLPGPLT | 561 | P63132 | |
| VVHHPQLVGQTVLNP | 551 | Q99583 | |
| LDVSHNGLHSLPPEV | 681 | Q6NSJ5 | |
| QLELLETHGHLIPTG | 26 | Q8WVL7 | |
| VETLLTNHPPGHVLA | 231 | O94927 | |
| IHHPTPIQIQGIPTI | 201 | Q9UJV9 | |
| LPAELSLQHPETQIH | 2071 | A7KAX9 | |
| HLGQPHSTTIIIRDP | 1091 | P16144 | |
| LHPLQQLVLVPGHLQ | 91 | Q9UKI9 | |
| ITHIRAHTNLPGPLT | 561 | P63135 | |
| ITHIRAHTNLPGPLT | 561 | Q9BXR3 | |
| HPHLSQDPLTGQTIL | 341 | Q14541 | |
| VLLCHSQNPPLNLTH | 321 | Q9H7L2 | |
| THITLHVIDINDNPP | 436 | Q9Y5H0 | |
| ITHIRAHTNLPGPLT | 561 | Q9QC07 | |
| HHLVNLPPSQTGLVR | 326 | Q9Y4H2 | |
| EPLHIDSLNHVQGTP | 46 | Q3L8U1 | |
| VNHIQDLISLSHEPP | 1921 | P42858 | |
| DILPLFGVLQPHSSH | 1331 | Q4G0P3 | |
| SGLPQHLIHFVQVQP | 121 | H3BNL1 | |
| LPIQTVTAPDLHNHP | 791 | Q9NYF0 | |
| AQNLVLIPLHAAPHQ | 161 | Q92874 | |
| IINVTVPGHDPHITK | 361 | P14384 | |
| HIHLPTEQPEASLVL | 11 | Q96N68 | |
| DLVLSHTPGQPLHIK | 891 | Q4L180 | |
| PLHIKVTPDHVQNTA | 901 | Q4L180 | |
| HHATPPQAQPEVKTL | 296 | Q53HC0 | |
| LAPHRVPLSQTNHAL | 371 | Q7Z7M9 | |
| HQDLSQGHEVQLPPV | 406 | Q2WGN9 | |
| QHVPGTQPHLDQSIV | 261 | Q5JTY5 | |
| QHVPGTQPHLDQSIV | 261 | Q4V339 | |
| LHPCGPIIQATHQNL | 291 | Q99871 | |
| QLPESDITVHVPQGH | 226 | Q6ZN28 | |
| AHPLPVLHLANTTLS | 621 | O60476 | |
| PVHPEELQHTNRLNG | 1026 | O75578 | |
| NHLAIEQPNTHLPET | 111 | P15382 | |
| HSHVLVDSLGLIPQI | 701 | A4D0S4 | |
| HPGEINSLVAHTKPV | 11 | Q1W209 | |
| LSLHHNELQALPGPV | 211 | Q6NUI6 | |
| IPVLHEGAENRQVHP | 96 | O95817 | |
| HPDNQVIVQSGRHPT | 1281 | Q9BY12 | |
| QSLHPLLVSAQGVHI | 716 | O43933 | |
| DTIHPPDHVIGNQIN | 526 | Q8N323 | |
| PIQVSALHHSPPLVQ | 1206 | Q9BZA8 | |
| PLHLAVQQAHVGLVP | 671 | Q96AX9 | |
| DHPLVPHGLSVVLTS | 351 | Q8IWW8 | |
| QHHEELSATPTPLGL | 201 | Q9Y5Y5 | |
| HPIIPIHNSLERQTE | 86 | O95397 | |
| LPDVNSHVIGHLKPN | 2976 | O75445 | |
| HLKENVPSHLPQVTV | 86 | Q96BD8 | |
| QLPDTSISIHVPEGH | 331 | Q9P0V3 | |
| DGPHLHTLTQPIVVT | 221 | H3BV60 | |
| QGQPLHIRVTPDHEN | 906 | Q7Z7B0 | |
| HPPQHVVGNQINILL | 526 | Q6UWF7 | |
| VQPSLLNPIHSEHIV | 716 | P48380 | |
| HIISPDQIHLTINPG | 96 | Q14872 | |
| SHLLEPHEIPLNVNT | 221 | P57071 | |
| LQEVLQSHGPPTHRL | 411 | Q6ZNJ1 | |
| QSHGPPTHRLLQELL | 416 | Q6ZNJ1 | |
| HVAANTLPHLTIPAV | 2601 | Q8NFP9 | |
| KTQHELDHNGLVPLP | 256 | Q96QT6 | |
| IHHSTPIRNQVPALQ | 276 | Q9UPW6 | |
| VLTLIPQPQHHGTSL | 201 | Q9Y286 | |
| RHQQVPHILQGLLSP | 961 | Q9Y2K2 | |
| ATHVLLVEPILNPAH | 1596 | Q149N8 | |
| GTLEQLQFIPGHHLP | 511 | A6NL88 | |
| NVLHHVIPAALNPII | 281 | Q8NH54 | |
| RIQPSIHDHNIPTLE | 956 | P20701 | |
| LTNQTVHRLLLPHPS | 156 | Q12769 | |
| SPLQLQKGHVSHPQI | 321 | P35712 | |
| VVPEQHASVAGQHPL | 41 | Q9C0B6 | |
| TVNGTPVNHQPLERH | 11 | P08912 | |
| AQGVHPQHLPSLLQT | 836 | Q9NRA8 | |
| AIGRLHSHVVPQPVN | 316 | O00327 | |
| HSHVVPQPVNGEIRV | 321 | O00327 | |
| THEQPHTQPQVSLLA | 461 | Q9ULV3 | |
| LHQLIHPEILPSEFG | 236 | Q5SYC1 | |
| LHAQLRGLQIPHEPE | 241 | Q8NFZ5 | |
| TVLHLILPESPGSHE | 1561 | Q63HN8 | |
| GQLVVIPSDHLPHFA | 856 | O15417 | |
| HINLPDLVQQSHSPA | 926 | Q9UKE5 | |
| PSHIQGNITPHAIVI | 1231 | Q9UKE5 | |
| PNLSHDRIVHINSIP | 231 | Q9UMS6 | |
| QHHQVPLALVTLGGI | 191 | A6NGC4 | |
| HVPHLSPAVIPTLQN | 76 | O75970 | |
| LHAHQALPVLQAQPL | 566 | Q9HCS4 | |
| EAVHTTHLLVQGPPF | 216 | Q9UPX0 | |
| QLLPHGENLQDVLPH | 101 | A6NFA1 | |
| NIPAISELLHTPAHV | 726 | Q8IWA0 | |
| HLHTVQLRLQPQEAP | 436 | Q96HA7 | |
| QHIIHQPIQSRPPVT | 266 | Q9H0E3 | |
| HITRALHNPGHVIQP | 131 | D6R9N7 | |
| LHNPGHVIQPSQALA | 136 | D6R9N7 | |
| ITHIRAHTNLPGPLT | 561 | P63133 | |
| IEASVHISQLPQHPL | 86 | Q5T1R4 | |
| HITRALHNPGHVIQP | 131 | A8MUK1 | |
| LHNPGHVIQPSQALA | 136 | A8MUK1 | |
| HITRALHNPGHVIQP | 131 | D6R901 | |
| LHNPGHVIQPSQALA | 136 | D6R901 | |
| HITRALHNPGHVIQP | 131 | C9JLJ4 | |
| LHNPGHVIQPSQALA | 136 | C9JLJ4 | |
| PVQFQVVELPSGHHL | 891 | O43847 | |
| ITHIRAHTNLPGPLT | 561 | Q9UQG0 | |
| HITRALHNPGHVIQP | 131 | D6RCP7 | |
| LHNPGHVIQPSQALA | 136 | D6RCP7 | |
| SHPSGIQAHTQLQLP | 486 | Q9Y6S9 | |
| NNITALVTPLPVGHH | 1796 | Q86WI1 | |
| HNPGQDLVIHRTSVP | 96 | Q9UKN8 | |
| ASIISIHPKIQEHQP | 251 | Q13530 | |
| PLLHSLVGQHILSVQ | 1916 | P27708 | |
| HPHEPISFGIDQILN | 11 | O43711 | |
| LPAFATIPIHQLQHE | 81 | Q86UK7 | |
| TEGHIPFPQHLNIIT | 116 | O14668 | |
| HITRALHNPGHVIQP | 131 | C9JPN9 | |
| LHNPGHVIQPSQALA | 136 | C9JPN9 | |
| HITRALHNPGHVIQP | 131 | Q0WX57 | |
| LHNPGHVIQPSQALA | 136 | Q0WX57 | |
| LHSPGHVIQPSQVLA | 136 | P0C7H9 | |
| EPLSLPGILHFIQHE | 61 | Q9NRL3 | |
| HITRALHNPGHVIQP | 131 | Q6QN14 | |
| LHNPGHVIQPSQALA | 136 | Q6QN14 | |
| HITRALHNPGHVIQP | 131 | D6RA61 | |
| LHNPGHVIQPSQALA | 136 | D6RA61 | |
| LGDLVINTNHPVVIH | 111 | Q53S58 | |
| PLEIVSIPDNHGHID | 171 | P49788 | |
| HITRALHNPGHVIQP | 131 | C9J2P7 | |
| LHNPGHVIQPSQALA | 136 | C9J2P7 | |
| HITRALHNPGHVIQP | 131 | D6RBQ6 | |
| LHNPGHVIQPSQALA | 136 | D6RBQ6 | |
| PDHNLLSQPKEHSIV | 56 | Q8NFP0 | |
| HITRALHNPGHVIQP | 131 | D6RBM5 | |
| LHNPGHVIQPSQALA | 136 | D6RBM5 | |
| IPHEPVINSSNVHVG | 351 | Q14966 | |
| QVTHELGILQSLQHP | 2836 | O75962 | |
| HITRALHNPGHVIQP | 131 | D6RJB6 | |
| LHNPGHVIQPSQALA | 136 | D6RJB6 | |
| LHIPGHVIQPSQALA | 136 | C9JJH3 | |
| LPHHEPISFGIDQIL | 11 | O43763 | |
| HITRALHNPGHVIQP | 131 | C9JVI0 | |
| LHNPGHVIQPSQALA | 136 | C9JVI0 | |
| APPATQDVHVLPHLQ | 671 | Q5EBL2 | |
| HHGETVLPSLDLSPQ | 656 | P23276 | |
| HLSPQPEELHLSPQT | 796 | O14686 | |
| PPHLEELHTQAQEGL | 56 | Q9P206 | |
| PQAPLHSVVQQLHGK | 396 | Q15418 | |
| PLHLAIIHGQTSVIE | 491 | Q00653 | |
| LHQTPLHLAVITGQT | 526 | Q00653 |